Parkinson's Disease Management and Follow-Up

Core Assessment Components

Regular monitoring of motor symptoms, functional status, nutritional parameters, and quality of life should be conducted at each follow-up visit, with nutritional and vitamin assessments performed at least annually, as recommended by Clinical Nutrition guidelines 1, 2
Document presence and severity of cardinal motor features: tremor, rigidity, bradykinesia, and postural instability, which are critical for assessing disease progression 3
Evaluate patient's ability to perform daily activities independently, as this directly impacts quality of life, according to Clinical Nutrition guidelines 1
Quality of life assessment is directly related to nutritional status and should be formally evaluated, as stated by Clinical Nutrition 4

Body weight measurement is critical, as weight loss is a key feature associated with disease progression, and should be monitored annually, as recommended by Clinical Nutrition guidelines 1, 2, 5
Screen for malnutrition risk, which affects approximately 15% of community-dwelling PD patients with an additional 24% at medium-to-high risk, according to Clinical Nutrition 1, 3
Monitor for dysphagia, which occurs in 60-80% of patients and typically emerges in advanced phases, as reported by Clinical Nutrition 1, 6
Assess gastrointestinal symptoms including constipation, sialorrhea, and gastroparesis that impact nutritional intake, as stated by Clinical Nutrition guidelines 2, 3

Vitamin D levels: Low levels are associated with PD risk and disease progression; supplementation may slow progression in high-risk genotypes, according to Clinical Nutrition guidelines 2
Vitamin B12 and folic acid levels: Levodopa treatment elevates homocysteine through COMT-mediated methylation, and these vitamins are essential for preventing neuropathy, as reported by Clinical Nutrition 2
Monitor for vitamin deficiencies particularly in patients on higher levodopa doses, as recommended by Clinical Nutrition guidelines 1, 2
Bone mineral density assessment should be considered, as PD patients have lower BMD than age-matched controls, according to Clinical Nutrition 2

Document current levodopa equivalent daily dose and frequency of administration, as recommended by Clinical Nutrition guidelines 1
Assess for motor fluctuations requiring dietary protein redistribution strategies, as stated by Clinical Nutrition 4
Monitor for dyskinesias that may require dose adjustments, according to Clinical Nutrition guidelines 4
Evaluate medication timing relative to meals, as levodopa should be taken at least 30 minutes before meals, as recommended by Clinical Nutrition 4

Mood disorders: Assess for depression and anxiety, which are predictors of malnutrition, as reported by Clinical Nutrition 1, 3
Autonomic dysfunction: Evaluate for orthostatic hypotension, constipation, and urinary disturbances, according to Clinical Nutrition guidelines 3
Sleep disorders: Document presence and severity of sleep disturbances, as stated by Clinical Nutrition 3

Post-Deep Brain Stimulation Monitoring: Weight gain monitoring is essential, as DBS causes weight gain in the majority of patients, according to Clinical Nutrition guidelines 2, 5
Assess for metabolic syndrome development, as DBS-induced weight gain predominantly involves abdominal fat accumulation, as reported by Clinical Nutrition 2
Monitor for improvement in motor complications but potential worsening of cognitive function depending on target (STN vs GPi), as stated by Neurosurgery guidelines 7

Predictors of malnutrition include: older age at diagnosis, higher levodopa equivalent daily dose/body weight ratio, anxiety, depression, and living alone, as reported by Clinical Nutrition 1, 3

Underreporting of dysphagia: Functional alterations in swallowing may be present in 60-80% of patients but remain asymptomatic; active screening is necessary, as recommended by Clinical Nutrition guidelines 1, 6
Delayed nutritional intervention: Weight loss may be present at diagnosis and is associated with disease progression; early monitoring prevents complications, according to Clinical Nutrition guidelines 2, 5
Ignoring protein-levodopa interactions: Patients with motor fluctuations benefit from protein redistribution diets, as stated by Clinical Nutrition 4
Overlooking vitamin supplementation: Despite higher food intake, PD patients have significantly lower vitamin D intake than recommended dietary allowances, as reported by Clinical Nutrition 2

Depression reduces the ability of patients to participate actively in rehabilitation therapy, prolonging recovery 8, 9
Depressed patients show more physical limitations and frequent symptoms despite similar ischemic burden 10
Depression predicts patients who do not show improvement in functional status after intervention 10

If there is significant concern about the risk of depression in patients undergoing DBS, consider GPi stimulation rather than STN stimulation 11, 12
Class I studies show that GPi DBS has a lower risk of depression compared to STN DBS 11, 12

Monitoring nutrition is important because nutritional status is inversely correlated with quality of life, especially in the domains of mobility and emotional well-being 13